A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...

California VC firm Aditum Bio is at it again, this time partnering up with China-based Mabwell Bioscience to launch a new biotech focused on cardiovascular disease. Aditum has paid Mabwell $12 million ...

Hood College has announced a new biotechnology training program that was launched using a nearly $1 million federal grant. The Innovative, Immersive Training Program in Synthetic Biology and ...

New Wave Biotech has launched a new Life Cycle Assessment (LCA) tool tailored to the biotechnology sector, designed to provide real-time visibility into the ...

Genscript Biotech ( ($HK:1548) ) just unveiled an announcement. Genscript Biotech Corporation announced that its associate, Legend Biotech ...